Li, Hojun https://orcid.org/0000-0002-8129-0390
Côté, Parker
Kuoch, Michael https://orcid.org/0000-0003-1229-7879
Ezike, Jideofor
Frenis, Katie https://orcid.org/0000-0003-4103-0882
Afanassiev, Anton
Greenstreet, Laura
Tanaka-Yano, Mayuri https://orcid.org/0000-0001-6309-3273
Tarantino, Giuseppe https://orcid.org/0000-0002-6078-6856
Zhang, Stephen
Whangbo, Jennifer
Butty, Vincent L. https://orcid.org/0000-0003-1173-2429
Moiso, Enrico https://orcid.org/0000-0002-4405-8357
Falchetti, Marcelo https://orcid.org/0000-0002-9438-680X
Lu, Kate
Connelly, Guinevere G. https://orcid.org/0000-0003-4861-8574
Morris, Vivian
Wang, Dahai
Chen, Antonia F. https://orcid.org/0000-0003-2040-8188
Bianchi, Giada
Daley, George Q. https://orcid.org/0000-0002-6346-5919
Garg, Salil
Liu, David
Chou, Stella T.
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Lummertz da Rocha, Edroaldo https://orcid.org/0000-0003-0537-4223
Schiebinger, Geoffrey https://orcid.org/0000-0002-8290-7997
Rowe, R. Grant https://orcid.org/0000-0003-3620-2950
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK134515, R03DK126729, K08DK123414)
Charles W. and Jennifer C. Johnson Cancer Research Fund American Society of Hematology
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (P30CA14051)
Instituto Nacional de Ciência e Tecnologia de Informação Quântica
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U01HL134696)
Coordination for the Improvement of Higher Education Personnel, Brazil
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
Article History
Received: 29 November 2023
Accepted: 19 September 2024
First Online: 5 December 2024
Competing interests
: A.R. is a cofounder and equity holder of Celsius Therapeutics, an equity holder in Immunitas and was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. From 1 August 2020, A.R. is an employee of Genentech. From 13 December 2021, J.W. is an employee of Vor Biopharma. The other authors declare no competing interests.